These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17653499)

  • 21. [Patient-relevant end points in Alzheimer's disease].
    Frölich L
    Dtsch Med Wochenschr; 2006 May; 131(19 Suppl 1):S31-4. PubMed ID: 16688663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dementias: mostly clinico-neuropsychological or mostly psychometric diagnosis?].
    Spinnler H
    Ann Ist Super Sanita; 2005; 41(1):75-80. PubMed ID: 16037654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term rivastigmine treatment in a routine clinical setting.
    Minthon L; Wallin AK; Eriksson S; Wattmo C; Andreasen N
    Acta Neurol Scand; 2009 Mar; 119(3):180-5. PubMed ID: 18759798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Dementia: what the primary care physician must know about it].
    Wettstein A
    Praxis (Bern 1994); 2001 Oct; 90(40):1725-30. PubMed ID: 11680211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What do nurses expect from therapy of Alzheimer disease].
    Riesner C
    Krankenpfl J; 2005; 43(7-10):209. PubMed ID: 16515280
    [No Abstract]   [Full Text] [Related]  

  • 26. [Final IQWiG to Ginkgo biloba].
    Winckler T
    Pharm Unserer Zeit; 2009; 38(5):454-61. PubMed ID: 19711323
    [No Abstract]   [Full Text] [Related]  

  • 27. Dementia and Alzheimer's disease: a practical orientation.
    Abraham IL
    Nurs Clin North Am; 2006 Mar; 41(1):119-27, viii. PubMed ID: 16492458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Feldman H; Anand R; Blesa R; Dubois B; Gray J; Homma A; Mohr E; Morris JC; Parys W; Raschig A; Robillard A
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():61-4. PubMed ID: 9305520
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trials of treatment for noncognitive symptoms of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Homma A; Brodaty H; Bruno G; Cummings JL; Gilman S; Gracon S; McKeith IG
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():54-5. PubMed ID: 9305518
    [No Abstract]   [Full Text] [Related]  

  • 30. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical issues in dementia drug development. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Post SG; Beerman B; Brodaty H; Gaines AW; Gauthier SG; Geldmacher DS; Hill S; Homma A; Rossor MN; Whitehouse PJ; Winblad B
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():26-8. PubMed ID: 9305511
    [No Abstract]   [Full Text] [Related]  

  • 33. [Nootropic drugs: definition, classification, mechanism of action, clinical effectiveness, substances].
    Kuhlmey J
    Z Arztl Fortbild (Jena); 1994 Sep; 88(9):697-701. PubMed ID: 7975756
    [No Abstract]   [Full Text] [Related]  

  • 34. [Dementia therapy. Colleagues are very reticent about using drugs].
    MMW Fortschr Med; 2002 Apr; 144(17):50. PubMed ID: 12048856
    [No Abstract]   [Full Text] [Related]  

  • 35. [Outpatient treatment of patients suffering from Alzheimer dementia. Two exploratory studies on the characteristics of therapy in medical practice].
    Haupt M; Rosenfeld S; Stoppe G
    MMW Fortschr Med; 2004 Aug; 146 Suppl 2():51-6. PubMed ID: 16739359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual case of nightmares with galantamine.
    Iraqi A; Hughes TL
    J Am Geriatr Soc; 2009 Mar; 57(3):565. PubMed ID: 19278402
    [No Abstract]   [Full Text] [Related]  

  • 37. Measuring quality of life in dementia: purposes, goals, challenges and progress.
    Rabins PV; Black BS
    Int Psychogeriatr; 2007 Jun; 19(3):401-7. PubMed ID: 17346364
    [No Abstract]   [Full Text] [Related]  

  • 38. Galantamine for Alzheimer's disease and mild cognitive impairment.
    Cusi C; Cantisani TA; Celani MG; Incorvaia B; Righetti E; Candelise L;
    Neuroepidemiology; 2007; 28(2):116-7. PubMed ID: 17409773
    [No Abstract]   [Full Text] [Related]  

  • 39. Alzheimer's disease: issues and challenges in primary care.
    Cotter VT
    Nurs Clin North Am; 2006 Mar; 41(1):83-93, vi. PubMed ID: 16492455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrating patient and informant reports on the Cornell-Brown Quality-of-Life Scale.
    Ready RE; Ott BR
    Am J Alzheimers Dis Other Demen; 2007 Dec-2008 Jan; 22(6):528-34. PubMed ID: 18166612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.